![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Concomitant Proton Pump Inhibitor Use Does Not Reduce the Efficacy of Elbasvir/Grazoprevir
|
|
|
Reported by Jules Levin
American Association for the Study of Liver Disease Boston, MA
November 11-15, 2016
Nancy Reau, MD1; Michael N. Robertson, MD2; Hwa-Ping Feng, PhD2; Luzelena Caro, PhD2; Wendy W. Yeh, MD2; Bach-Yen T. Nguyen, MD2; Janice Wahl, MD2; Eliav Barr, MD2; Peggy Hwang, PhD2; Stephanie O. Klopfer, PhD2
1Rush University Medical Center, Chicago, IL, USA; 2Merck & Co., Inc., Kenilworth, NJ, USA
![HIV1](../images/111416/111416-3/HIV1.gif)
![HIV2](../images/111416/111416-3/HIV2.gif)
![HIV3](../images/111416/111416-3/HIV3.gif)
![HIV4](../images/111416/111416-3/HIV4.gif)
![HIV5](../images/111416/111416-3/HIV5.gif)
![HIV6](../images/111416/111416-3/HIV6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|